Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Annexin V-Cy5/DAPI Apoptosis Kit: High-Fidelity Detection...

    2026-03-26

    Annexin V-Cy5/DAPI Apoptosis Kit: High-Fidelity Detection of Cell Death

    Executive Summary: The Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255, APExBIO) enables sensitive detection of cell apoptosis and necrosis within 10–20 minutes via phosphatidylserine (PS) exposure and DAPI nuclear staining (internal link). Annexin V-Cy5 binds externalized PS, an early apoptosis marker, while DAPI labels cells with compromised membranes, distinguishing apoptotic from necrotic populations (internal link). The kit is optimized for use in both flow cytometry and fluorescence microscopy. It supports rapid, reproducible workflow integration for cancer, immunology, and neurodegenerative research. Its reagents remain stable for up to six months when stored at 2–8°C and protected from light (product page).

    Biological Rationale

    Apoptosis is a form of programmed cell death characterized by membrane phospholipid changes, DNA fragmentation, and caspase activation. During early apoptosis, phosphatidylserine (PS) is translocated from the inner to the outer plasma membrane leaflet, marking cells for clearance (internal link). Annexin V, a 35–36 kDa protein, binds PS with nanomolar affinity in a calcium-dependent manner, providing a quantifiable apoptosis marker (van Engeland 1998, DOI). Necrotic cells, in contrast, lose membrane integrity, permitting nuclear dyes such as DAPI to penetrate and bind DNA. Differentiating apoptosis from necrosis is critical in cancer research, drug screening, and disease modeling (internal link). The Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) model illustrates the significance of apoptosis detection in translational oncology (Li et al. 2025, DOI).

    Mechanism of Action of Annexin V-Cy5/DAPI Apoptosis Kit

    The kit leverages two molecular probes for cell death discrimination:

    • Annexin V-Cy5: Binds PS exposed on the outer leaflet of the plasma membrane during early apoptosis; Cy5 fluorophore enables detection in the far-red channel (ex/em: ~650/670 nm).
    • DAPI: A membrane-impermeant, blue-fluorescent dye (ex/em: ~358/461 nm) that stains nuclear DNA in cells with compromised membranes (late apoptosis/necrosis).

    Upon incubation (10–20 min, room temperature, in calcium-containing binding buffer), live cells remain Annexin V–/DAPI–, early apoptotic cells are Annexin V+/DAPI–, and necrotic or late apoptotic cells are Annexin V+/DAPI+ (reference). This dual-staining approach enables high-content, quantitative cell death analysis in single-cell suspensions or adherent cultures (reference).

    Evidence & Benchmarks

    • Annexin V-Cy5 detects PS externalization with sub-nanomolar sensitivity in viable cell suspensions (van Engeland 1998, DOI).
    • DAPI discriminates necrotic or late apoptotic cells by nuclear penetration only when membrane integrity is compromised (Spector 1978, DOI).
    • The Annexin V-Cy5/DAPI Apoptosis Kit allows apoptosis/necrosis quantification in as little as 10 minutes, outperforming multi-step TUNEL or caspase assays for speed (internal).
    • P2RX1-mediated apoptosis in Ph+ ALL models is validated by increased Annexin V+ populations following tyrosine kinase inhibitor exposure (Li et al. 2025, DOI).
    • Staining is compatible with both flow cytometry (488/640 nm lasers) and fluorescence microscopy, with minimal spectral overlap in multi-color panels (product page).

    Applications, Limits & Misconceptions

    Primary applications:

    • Quantitative apoptosis/necrosis analysis in cancer research, particularly for drug-induced cytotoxicity (e.g., TKIs in leukemia).
    • Cell death assays in neurodegenerative disease, immune cell studies, and pharmacology (internal).
    • Differentiation of early versus late apoptosis in mechanistic cell death studies (internal).
    • Workflow integration for high-throughput screening (HTS) in multiwell formats.

    This article extends previous reviews by providing granular, evidence-backed limits and clarifications for the K2255 kit.

    Common Pitfalls or Misconceptions

    • Not a caspase activity assay: The kit detects membrane changes, not direct caspase activity—apoptosis can occur independently of caspase activation.
    • Cannot distinguish primary necrosis from late apoptosis: Both result in Annexin V+/DAPI+ staining; additional markers are required for mechanistic resolution.
    • Requires calcium in binding buffer: Omission leads to false negatives, as Annexin V-PS binding is calcium-dependent.
    • Not validated for in vivo imaging: The kit is optimized for ex vivo single-cell suspensions or adherent cells, not for in situ tissue staining.
    • Fluorophore stability: Cy5 and DAPI are light-sensitive; prolonged exposure or incorrect storage can reduce signal.

    Workflow Integration & Parameters

    All components (Annexin V-Cy5, DAPI, 10X binding buffer) must be stored at 2–8°C and protected from light. Recommended workflow:

    1. Harvest 1–5 x 105 cells/sample and wash in cold PBS.
    2. Resuspend cells in 1X binding buffer containing 2.5 mM CaCl2 (final concentration).
    3. Add 5 μL Annexin V-Cy5 and 1 μL DAPI per 100 μL cell suspension.
    4. Incubate 10–20 min at room temperature, protected from light.
    5. Analyze by flow cytometry (Cy5/DAPI channels) or fluorescence microscopy.

    For high-throughput or scenario-driven guidance, see this workflow Q&A, which this article updates by incorporating recent mechanistic advances in PS externalization and cell death pathway analysis.

    Conclusion & Outlook

    The APExBIO Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255) provides robust, high-sensitivity discrimination of apoptotic and necrotic cells for cell death research. Its rapid, one-step protocol and dual-color readout enable precise, reproducible apoptosis quantification in cancer, neurodegenerative, and immunological studies. As new cell death pathways (e.g., caspase-independent, P2RX1-mediated apoptosis) are discovered, dual-parameter approaches such as this kit will remain critical for mechanistic and translational research (Li et al. 2025). For further product details, visit the Annexin V-Cy5/DAPI Apoptosis Kit page.